SOTERIX MEDICAL, INC. — Department of Defense SBIR Phase I: DHA192-002
SOTERIX MEDICAL, INC. — SBIR Phase I award from Department of Defense.
Phase I SBIR feasibility signal
- Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from Department of Defense in a technical approach.
- Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
- Obligated amount $249,961. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Topic code DHA192-002 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $249,961
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase I
- Topic
- DHA192-002
- Solicitation
- 19.2
- NAICS
- —
- Place of performance
- NY
- Period
- 2020-01-21 → 2020-08-20
Description
Galvanic Vestibular Stimulation (GVS) is an electrical stimulation technique that stimulates the vestibular nerves through electrodes that are placed on the mastoid bones behind the ears. GVS is non-invasive, low-cost and well tolerated. There is evidence